# Use of (-)-Epicatechin in the Treatment of Becker Muscular Dystrophy (Pilot Study)

> **NCT01856868** · PHASE1,PHASE2 · COMPLETED · sponsor: **Craig McDonald, MD** · enrollment: 7 (actual)

## Conditions studied

- Becker Muscular Dystrophy

## Interventions

- **DRUG:** (-)-epicatechin

## Key facts

- **NCT ID:** NCT01856868
- **Lead sponsor:** Craig McDonald, MD
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-05
- **Primary completion:** 2018-09
- **Final completion:** 2018-09
- **Target enrollment:** 7 (ACTUAL)
- **Last updated:** 2021-12-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01856868

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01856868, "Use of (-)-Epicatechin in the Treatment of Becker Muscular Dystrophy (Pilot Study)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01856868. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*